Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Insulinoma
ADR ID BADD_A02368
ADR Hierarchy
05      Endocrine disorders
05.08      Neoplastic and ectopic endocrinopathies
05.08.01      Endocrine neoplasms NEC
05.08.01.004      Insulinoma
07      Gastrointestinal disorders
07.21      Malignant and unspecified neoplasms gastrointestinal NEC
07.21.09      Pancreatic neoplasms
07.21.09.001      Insulinoma
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.24      Endocrine neoplasms malignant and unspecified
16.24.02      Islet cell neoplasms and APUDoma NEC
16.24.02.003      Insulinoma
Description A benign tumor of the PANCREATIC BETA CELLS. Insulinoma secretes excess INSULIN resulting in HYPOGLYCEMIA. [MeSH]
MedDRA Code 10022498
MeSH ID D007340
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Insulinoma | Insulinomas | Adenoma, beta-Cell | Adenoma, beta Cell | Adenomas, beta-Cell | beta-Cell Adenoma | beta-Cell Adenomas | Insuloma | Insulomas | beta-Cell Tumor | Tumor, beta-Cell | Tumors, beta-Cell | beta Cell Tumor | beta-Cell Tumors
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00417Cetirizine0.000043%
BADD_D00858Everolimus0.000229%
BADD_D01401Metformin0.000011%
BADD_D02073Streptozocin--
BADD_D02568Lutetium oxodotreotide lu-177-
The 1th Page    1    Total 1 Pages